🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Adverse Effects of ATG/ALG Therapy in Aplastic Anemia

Recruitingn/aAges any - anyAllInstitute of Hematology & Blood Diseases Hospital…
NCT07461116 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This prospective, single-center, observational cohort study aims to systematically observe and describe the clinical characteristics of adverse reactions in patients with aplastic anemia undergoing ATG (Anti-Thymocyte Globulin) /ALG (Anti-Lymphocyte Globulin) treatment, providing a data foundation for the development of relevant management strategies. This study plans to enroll 200 aplastic anemia patients undergoing ATG/ALG treatment

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Meet the diagnostic criteria for aplastic anemia (Camitta criteria); * Receiving ATG/ALG immunosuppressive therapy for the first time; Exclusion Criteria: * Previously received hematopoietic stem cell transplantation; * Aplastic anemia patients receiving ATG/ALG as part of transplant conditioning regimen;
💊

What it tests

  • ATG/ALG
📍

Where

1 site
Regenerative Medicine Center and Red Blood Cell Disorders Center
Tianjin, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy